Imaging Features and Misdiagnosis Analysis of Hyaline Vascular Castleman Disease in the Parotid Region: A Case Report

doi:10.37015/AUDT.2023.220048

Advanced Ultrasound in Diagnosis and Therapy ›› 2023, Vol. 7 ›› Issue (3): 302-304.doi: 10.37015/AUDT.2023.220048

• Case Reports • Previous Articles

Imaging Features and Misdiagnosis Analysis of Hyaline Vascular Castleman Disease in the Parotid Region: A Case Report

Pengyan Zhang, MS^a, Ling Ren, MD^a, Yuguang You, BS^a, Wenjun Xiao, MS^a^,^*()

^a Department of Ultrasonography, Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China

Received:2022-12-16 Revised:2023-02-07 Accepted:2023-03-11 Online:2023-09-30 Published:2023-10-09
Contact: Wenjun Xiao, MS, E-mail:gyfyxwj@163.com

Richhtml ( 7 ) PDF ( 53 )

Abstract

Abstract:

Castleman disease (CD), first described in 1954, is a rare lymphoproliferative disorder. A 20-year-old female patient was treated for a "painless mass below the right ear for 1 year". The imagological examination of the patient showed a soft tissue mass about 2.8 cm in diameter in the right parotid gland. Moreover, the patient underwent a right superficial parotidectomy and facial nerve dissection. The mass in the parotid gland was removed, and CD was confirmed by further pathological examination. Imagological examination contributes to the diagnosis and preoperative evaluation of CD.

Key words: Castleman disease; Hyaline vascular; Parotid gland; Case report

Pengyan Zhang, MS, Ling Ren, MD, Yuguang You, BS, Wenjun Xiao, MS. Imaging Features and Misdiagnosis Analysis of Hyaline Vascular Castleman Disease in the Parotid Region: A Case Report. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(3): 302-304.

Figures/Tables 2

References 15

[1]	Schulte KM, Talat N. Castleman's disease--a two compartment model of HHV8 infection. Nat Rev Clin Oncol 2010; 7:533-543. doi: 10.1038/nrclinonc.2010.103
[2]	Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9:822-830. doi: 10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4 pmid: 13356266
[3]	Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood 2020; 135:1353-1364. doi: 10.1182/blood.2019000931 pmid: 32106302
[4]	Carbone A, Borok M, Damania B, Gloghini A, Polizzotto MN, Jayanthan RK, et al. Castleman disease. Nat Rev Dis Primers 2021; 7:84. doi: 10.1038/s41572-021-00317-7 pmid: 34824298
[5]	Huang Z, Jin T, Zhang X, Wu Z. Pancreatic mass found to be Castleman disease, a rare case report. Asian J Surg 2020; 43:767-768.
[6]	Pai SA, Naresh KN, Borges AM. Report of a case with clinical and pathologic features of castleman disease that predates Castleman's report by more than 50 years. Arch Pathol Lab Med 2022; 146:1412-1415.
[7]	Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29:670-683. doi: 10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-# pmid: 4551306
[8]	Munshi N, Mehra M, van de Velde H, Desai A, Potluri R, Vermeulen J. Use of a claims database to characterize and estimate the incidence rate for Castleman disease. Leuk Lymphoma 2015; 56:1252-1260.
[9]	Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 2017; 129:1646-1657. doi: 10.1182/blood-2016-10-746933 pmid: 28087540
[10]	Altinbas NK, Gundogdu Anamurluoglu E, Oz II, Yuce C, Yagci C, Ustuner E, et al. Real-time sonoelastography of parotid gland tumors. J Ultrasound Med 2017; 36:77-87. doi: 10.7863/ultra.16.02038 pmid: 27925646
[11]	Angang D, Jia L, Xia G, Ping X, Jiang L. Gray scale and doppler ultrasonography features of the carcinoma ex pleomorphic adenoma. Dentomaxillofac Radiol 2018; 47:20170268.
[12]	Wang CW, Chu YH, Chiu DY, Shin N, Hsu HH, Lee JC, et al. JOURNAL CLUB: the warthin tumor score: a simple and reliable method to distinguish warthin tumors from pleomorphic adenomas and carcinomas. AJR Am J Roentgenol 2018; 210:1330-1337. doi: 10.2214/AJR.17.18492
[13]	Quer M, Hernandez-Prera JC, Silver CE, Casasayas M, Simo R, Vander Poorten V, et al. Current trends and controversies in the management of warthin tumor of the parotid gland. Diagnostics (Basel) 2021; 11:1467.
[14]	Tretiakow D, Stodulski D, Skorek A. Regarding the concurrent presence of secretory carcinoma and Warthin's tumor in the ipsilateral parotid gland. Oral Oncol 2020; 109:104763. doi: 10.1016/j.oraloncology.2020.104763
[15]	Jechova A, Kuchar M, Novak S, Koucky V, Dostalova L, Zabrodsky M, et al. The role of fine-needle aspiration biopsy (FNAB) in Warthin tumour diagnosis and management. Eur Arch Otorhinolaryngol 2019; 276:2941-2946. doi: 10.1007/s00405-019-05566-7 pmid: 31321502

Imaging Features and Misdiagnosis Analysis of Hyaline Vascular Castleman Disease in the Parotid Region: A Case Report

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 15

Related Articles 3

Metrics

Comments

[1]	Yanling Chen, MM, Hantao Wang, MM, Hong Han, PhD, Yi Dong, PhD, Wen-ping Wang, MD. Contrast-enhanced Ultrasound of Undifferentiated Embryonal Sarcoma of the Liver in Adult: Two Cases Report and Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(4): 204-209.
[2]	Xiaohui Ji, MD, Juanjuan Li, MD, Dongxia Gao, MD. Ultrasound-guided Microwave Ablation of Adenolymphoma of Parotid Gland: A Case Report [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(1): 22-25.
[3]	Danqing Huang, MS, Min Tang, MS, Aimei Li, MD, Decai Yu, MD, Jun Chen, MD, Min Wu, MS, Wenping Wang, MD, Wentao Kong, MD. Neurofibromatosis with Intrahepatic, Retroperitoneal and Pelvic Involvement: A Case Report and Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2022, 6(1): 29-32.